Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abeona Therapeutics Inc. - Common Stock
(NQ:
ABEO
)
5.490
+0.225 (+4.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abeona Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
Next >
Which stocks have an unusual volume on Thursday?
May 01, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via
Chartmill
Wednesday's session: top gainers and losers
April 30, 2025
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease
April 30, 2025
Abeona's Zevaskyn secures timely FDA nod, priced at $3.1 million, with 2025 sales now forecast at $31.6 million and peak U.S. revenue projected at $600 million.
Via
Benzinga
Exposures
Product Safety
Abeona Stock Surges to 52-Week High: What's Behind The Move?
April 30, 2025
Abeona shares are trading higher on Wednesday on possible continued strength after the FDA announced approval for its gene therapy.
Via
Benzinga
Exposures
Product Safety
Top stock movements in today's session.
April 30, 2025
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 30, 2025
Via
Benzinga
Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy
April 29, 2025
FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.
Via
Benzinga
Exposures
Product Safety
Abeona Therapeutics’ Gene Therapy Gets FDA Nod For Treating Rare Genetic Skin Disease
April 29, 2025
ZEVASKYN is expected to be available beginning in the third quarter of 2025 through ZEVASKYN Qualified Treatment Centers, located across the U.S. with experience in cell and gene therapy.
Via
Stocktwits
Exposures
Product Safety
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
March 05, 2025
Via
Benzinga
ABEO Stock Earnings: Abeona Therapeutics Beats EPS for Q2 2024
August 12, 2024
ABEO stock results show that Abeona Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 30, 2024
Via
Benzinga
ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024
May 15, 2024
ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Crude Oil Moves Higher; General Motors Earnings Top Views
April 23, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 23, 2024
Via
Benzinga
Dow Jumps Over 200 Points; US Services PMI Falls In April
April 23, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Affirm (AFRM) Stock Moving Today?
April 23, 2024
Affirm stock is falling on Tuesday as AFRM investors react to BNPL loan service One being added to Walmart's retail stores.
Via
InvestorPlace
US Stocks Higher; PepsiCo Posts Upbeat Earnings
April 23, 2024
Via
Benzinga
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
April 23, 2024
Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Manufacturing and Controls requirements.
Via
Benzinga
Exposures
Product Safety
Why Is Greenwave Technology Solutions (GWAV) Stock Down 47% Today?
April 23, 2024
Greenwave Technology Solutions stock is down on Tuesday as GWAV investors react to a registered direct offering and private placement.
Via
InvestorPlace
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
April 23, 2024
Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel.
Via
InvestorPlace
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 23, 2024
Via
Benzinga
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
April 23, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 23, 2024
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!
Via
InvestorPlace
Calix Reports Mixed Results, Joins Cadence Design Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023
March 19, 2024
ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
February 08, 2024
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 27, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.